Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Prenen

Showing results (11-20 of 170) with videos related to

Pageof 17
Sort By:
Journal of Gastrointestinal Oncology|January 16, 2025
Challenges and prospects of LAG-3 inhibition in advanced gastric and gastroesophageal junction cancer: insights from the RELATIVITY-060 trialSofie Seghers, Andreas Domen, Hans Prenen
Critical Reviews in Oncology/Hematology|August 30, 2008
New therapeutic developments in renal cell cancerHans Prenen, Thierry Gil, Ahmad Awada
Current Opinion in Oncology|May 10, 2024
State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignanciesPieterjan Vanclooster, Sofie Seghers, Hans Prenen
JAMA Oncology|September 15, 2017
Is There Merit for MET-Targeted Therapies in Gastroesophageal Cancer?Massimiliano Mazzone, Veronica Finisguerra, Hans Prenen
The Oncologist|July 10, 2012
Overcoming resistance to antiangiogenic therapiesSabine Tejpar, Hans Prenen, Massimiliano Mazzone
Annals of Gastroenterology|April 12, 2016
Use of biologics and chemotherapy in patients with inflammatory bowel diseases and cancerAranzazu Jauregui-Amezaga, Séverine Vermeire, Hans Prenen
Targeted Oncology|May 7, 2013
Role of targeted agents in metastatic colorectal cancerHans Prenen, Loredana Vecchione, Eric Van Cutsem
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
New strategies for treatment of KRAS mutant metastatic colorectal cancerHans Prenen, Sabine Tejpar, Eric Van Cutsem
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Impact of molecular markers on treatment selection in advanced colorectal cancerHans Prenen, Sabine Tejpar, Eric Van Cutsem
BMC Research Notes|November 20, 2012
Pulmonary lymphangitic carcinomatosis as a primary manifestation of gastric carcinoma in a young adult: a case report and review of the literatureKim Moubax, Wim Wuyts, Vincent Vandecaveye, et al.
Pageof 17

Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
Journal of Gastrointestinal Oncology|January 16, 2025
Challenges and prospects of LAG-3 inhibition in advanced gastric and gastroesophageal junction cancer: insights from the RELATIVITY-060 trialSofie Seghers, Andreas Domen, Hans Prenen
Critical Reviews in Oncology/Hematology|August 30, 2008
New therapeutic developments in renal cell cancerHans Prenen, Thierry Gil, Ahmad Awada
Current Opinion in Oncology|May 10, 2024
State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignanciesPieterjan Vanclooster, Sofie Seghers, Hans Prenen
JAMA Oncology|September 15, 2017
Is There Merit for MET-Targeted Therapies in Gastroesophageal Cancer?Massimiliano Mazzone, Veronica Finisguerra, Hans Prenen
The Oncologist|July 10, 2012
Overcoming resistance to antiangiogenic therapiesSabine Tejpar, Hans Prenen, Massimiliano Mazzone
Annals of Gastroenterology|April 12, 2016
Use of biologics and chemotherapy in patients with inflammatory bowel diseases and cancerAranzazu Jauregui-Amezaga, Séverine Vermeire, Hans Prenen
Targeted Oncology|May 7, 2013
Role of targeted agents in metastatic colorectal cancerHans Prenen, Loredana Vecchione, Eric Van Cutsem
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
New strategies for treatment of KRAS mutant metastatic colorectal cancerHans Prenen, Sabine Tejpar, Eric Van Cutsem
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Impact of molecular markers on treatment selection in advanced colorectal cancerHans Prenen, Sabine Tejpar, Eric Van Cutsem
BMC Research Notes|November 20, 2012
Pulmonary lymphangitic carcinomatosis as a primary manifestation of gastric carcinoma in a young adult: a case report and review of the literatureKim Moubax, Wim Wuyts, Vincent Vandecaveye, et al.
Pageof 17